NO124336B - - Google Patents

Download PDF

Info

Publication number: NO124336B
Authority: NO; Norway
Prior art keywords: cells; solution; cgth; indicator; indicator system
Prior art date: 1966-06-28

Application number

NO16876467A

Other languages

English (en)

Norwegian (no)

Inventor

E Arquilla

Original Assignee

Miles Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1966-06-28

Filing date

1967-06-27

Publication date

1972-04-04

1967-06-27 Application filed by Miles Lab filed Critical Miles Lab

1969-10-13 Priority to NO406669A priority Critical patent/NO124337B/no

1972-04-04 Publication of NO124336B publication Critical patent/NO124336B/no

Links

230000000813 microbial effect Effects 0.000 claims description 45
239000000126 substance Substances 0.000 claims description 44
230000000890 antigenic effect Effects 0.000 claims description 40
239000007822 coupling agent Substances 0.000 claims description 28
230000001900 immune effect Effects 0.000 claims description 28
238000000034 method Methods 0.000 claims description 21
238000004519 manufacturing process Methods 0.000 claims description 7
239000003755 preservative agent Substances 0.000 claims description 7
230000002335 preservative effect Effects 0.000 claims description 6
230000001580 bacterial effect Effects 0.000 claims description 5
241000233866 Fungi Species 0.000 claims description 3
230000003108 parasitologic effect Effects 0.000 claims description 2
230000000717 retained effect Effects 0.000 claims description 2
210000004027 cell Anatomy 0.000 description 144
238000012360 testing method Methods 0.000 description 76
239000000243 solution Substances 0.000 description 71
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 63
230000004520 agglutination Effects 0.000 description 60
239000000523 sample Substances 0.000 description 57
210000002700 urine Anatomy 0.000 description 47
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 45
238000010790 dilution Methods 0.000 description 44
239000012895 dilution Substances 0.000 description 44
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
239000000427 antigen Substances 0.000 description 31
108091007433 antigens Proteins 0.000 description 31
102000036639 antigens Human genes 0.000 description 31
239000011780 sodium chloride Substances 0.000 description 28
239000000725 suspension Substances 0.000 description 25
239000000463 material Substances 0.000 description 24
239000012153 distilled water Substances 0.000 description 21
XUGUHTGSMPZQIW-UHFFFAOYSA-N [[4-(4-diazonioiminocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-ylidene]hydrazinylidene]azanide Chemical compound C1=CC(N=[N+]=[N-])=CC=C1C1=CC=C(N=[N+]=[N-])C=C1 XUGUHTGSMPZQIW-UHFFFAOYSA-N 0.000 description 19
210000002966 serum Anatomy 0.000 description 19
241000283973 Oryctolagus cuniculus Species 0.000 description 18
241000588724 Escherichia coli Species 0.000 description 17
239000000203 mixture Substances 0.000 description 16
239000012266 salt solution Substances 0.000 description 16
239000002245 particle Substances 0.000 description 15
230000035935 pregnancy Effects 0.000 description 13
239000011521 glass Substances 0.000 description 12
239000007788 liquid Substances 0.000 description 12
238000002156 mixing Methods 0.000 description 12
239000008363 phosphate buffer Substances 0.000 description 12
238000002360 preparation method Methods 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 10
210000003743 erythrocyte Anatomy 0.000 description 10
108091006905 Human Serum Albumin Proteins 0.000 description 9
102000008100 Human Serum Albumin Human genes 0.000 description 9
239000003153 chemical reaction reagent Substances 0.000 description 9
238000004587 chromatography analysis Methods 0.000 description 9
238000002347 injection Methods 0.000 description 9
239000007924 injection Substances 0.000 description 9
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 9
238000005119 centrifugation Methods 0.000 description 8
108010074605 gamma-Globulins Proteins 0.000 description 8
230000035931 haemagglutination Effects 0.000 description 8
210000004369 blood Anatomy 0.000 description 7
239000008280 blood Substances 0.000 description 7
239000006285 cell suspension Substances 0.000 description 7
238000010998 test method Methods 0.000 description 7
238000005406 washing Methods 0.000 description 7
241000589567 Brucella abortus Species 0.000 description 6
241000283073 Equus caballus Species 0.000 description 6
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
229940056450 brucella abortus Drugs 0.000 description 6
238000005859 coupling reaction Methods 0.000 description 6
238000001514 detection method Methods 0.000 description 6
239000001488 sodium phosphate Substances 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
102000004877 Insulin Human genes 0.000 description 5
108090001061 Insulin Proteins 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 5
239000000839 emulsion Substances 0.000 description 5
229940088597 hormone Drugs 0.000 description 5
239000005556 hormone Substances 0.000 description 5
229940125396 insulin Drugs 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
239000013068 control sample Substances 0.000 description 4
238000010168 coupling process Methods 0.000 description 4
239000012530 fluid Substances 0.000 description 4
239000006260 foam Substances 0.000 description 4
239000008098 formaldehyde solution Substances 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
238000003756 stirring Methods 0.000 description 4
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
210000005253 yeast cell Anatomy 0.000 description 4
MPSXGPCFLAGJOM-UHFFFAOYSA-M 2-tert-butyl-5-methyl-1,2-oxazol-2-ium;perchlorate Chemical compound [O-]Cl(=O)(=O)=O.CC1=CC=[N+](C(C)(C)C)O1 MPSXGPCFLAGJOM-UHFFFAOYSA-M 0.000 description 3
241000194103 Bacillus pumilus Species 0.000 description 3
241001134654 Lactobacillus leichmannii Species 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
241001494479 Pecora Species 0.000 description 3
241000589538 Pseudomonas fragi Species 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
210000000601 blood cell Anatomy 0.000 description 3
230000008878 coupling Effects 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
229910021641 deionized water Inorganic materials 0.000 description 3
229910000397 disodium phosphate Inorganic materials 0.000 description 3
235000019800 disodium phosphate Nutrition 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
238000005534 hematocrit Methods 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
238000013508 migration Methods 0.000 description 3
230000005012 migration Effects 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
235000014469 Bacillus subtilis Nutrition 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
108010058846 Ovalbumin Proteins 0.000 description 2
102000007562 Serum Albumin Human genes 0.000 description 2
108010071390 Serum Albumin Proteins 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
241000700605 Viruses Species 0.000 description 2
239000002250 absorbent Substances 0.000 description 2
230000002745 absorbent Effects 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000008272 agar Substances 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
229910000019 calcium carbonate Inorganic materials 0.000 description 2
229940041514 candida albicans extract Drugs 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
230000008859 change Effects 0.000 description 2
238000012412 chemical coupling Methods 0.000 description 2
229940015047 chorionic gonadotropin Drugs 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
239000013078 crystal Substances 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000000975 dye Substances 0.000 description 2
238000001802 infusion Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
229940092253 ovalbumin Drugs 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229910000160 potassium phosphate Inorganic materials 0.000 description 2
235000011009 potassium phosphates Nutrition 0.000 description 2
238000009597 pregnancy test Methods 0.000 description 2
239000000047 product Substances 0.000 description 2
235000010288 sodium nitrite Nutrition 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
235000011008 sodium phosphates Nutrition 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
241000894007 species Species 0.000 description 2
229940014800 succinic anhydride Drugs 0.000 description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
239000012138 yeast extract Substances 0.000 description 2
JXSSPZOCHGZWJP-UHFFFAOYSA-N 1,2-difluoro-3,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(F)=C1[N+]([O-])=O JXSSPZOCHGZWJP-UHFFFAOYSA-N 0.000 description 1
AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
241001530455 Antigone Species 0.000 description 1
244000186140 Asperula odorata Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
241000249497 Brucellaceae Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000588921 Enterobacteriaceae Species 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
235000008526 Galium odoratum Nutrition 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000006771 Gonadotropins Human genes 0.000 description 1
108010086677 Gonadotropins Proteins 0.000 description 1
206010018910 Haemolysis Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000976075 Homo sapiens Insulin Proteins 0.000 description 1
241001468155 Lactobacillaceae Species 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
102000001621 Mucoproteins Human genes 0.000 description 1
108010093825 Mucoproteins Proteins 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
241000947836 Pseudomonadaceae Species 0.000 description 1
XRTCNVGCKJGYDF-UHFFFAOYSA-N [[4-(4-diazonioimino-2,3-disulfocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-ylidene]hydrazinylidene]azanide Chemical compound OS(=O)(=O)C1=C(N=[N+]=[N-])C=CC(C=2C=CC(=CC=2)N=[N+]=[N-])=C1S(O)(=O)=O XRTCNVGCKJGYDF-UHFFFAOYSA-N 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
230000003698 anagen phase Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
238000012754 cardiac puncture Methods 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
229960003983 diphtheria toxoid Drugs 0.000 description 1
230000009189 diving Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000011790 ferrous sulphate Substances 0.000 description 1
235000003891 ferrous sulphate Nutrition 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
125000001153 fluoro group Chemical group F* 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
238000007429 general method Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000002622 gonadotropin Substances 0.000 description 1
230000005484 gravity Effects 0.000 description 1
230000012010 growth Effects 0.000 description 1
230000008588 hemolysis Effects 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
150000002466 imines Chemical class 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
230000036512 infertility Effects 0.000 description 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
238000002372 labelling Methods 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000003760 magnetic stirring Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
229910000403 monosodium phosphate Inorganic materials 0.000 description 1
235000019799 monosodium phosphate Nutrition 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
238000003825 pressing Methods 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000008569 process Effects 0.000 description 1
230000007065 protein hydrolysis Effects 0.000 description 1
239000005297 pyrex Substances 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000035322 succinylation Effects 0.000 description 1
238000010613 succinylation reaction Methods 0.000 description 1
229960004016 sucrose syrup Drugs 0.000 description 1
-1 sulphydryl (mercapto) groups Chemical group 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
238000012546 transfer Methods 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C14/00—Glass compositions containing a non-glass component, e.g. compositions containing fibres, filaments, whiskers, platelets, or the like, dispersed in a glass matrix
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C2214/00—Nature of the non-vitreous component
- C03C2214/02—Fibres; Filaments; Yarns; Felts; Woven material
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C2214/00—Nature of the non-vitreous component
- C03C2214/34—Nature of the non-vitreous component comprising an impregnation by molten glass step

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Geochemistry & Mineralogy (AREA)
Food Science & Technology (AREA)
Materials Engineering (AREA)
General Chemical & Material Sciences (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Dispersion Chemistry (AREA)
Ceramic Engineering (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO16876467A 1966-06-28 1967-06-27 NO124336B (2)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO406669A NO124337B (2)	1966-06-28	1969-10-13

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US56099766A	1966-06-28	1966-06-28

Publications (1)

Publication Number	Publication Date
NO124336B true NO124336B (2)	1972-04-04

Family

ID=24240231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO16876467A NO124336B (2)	1966-06-28	1967-06-27

Country Status (10)

Country	Link
AT (1)	AT287191B (2)
BE (1)	BE700570A (2)
CH (1)	CH526631A (2)
DE (1)	DE1617644A1 (2)
DK (2)	DK120254B (2)
ES (1)	ES341495A1 (2)
FI (1)	FI44301B (2)
NL (1)	NL6708328A (2)
NO (1)	NO124336B (2)
SE (1)	SE363679B (2)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4900685A (en) *	1987-01-29	1990-02-13	Cytosignet, Inc.	Analyte detection in particulate-containing samples

1967
- 1967-06-07 ES ES341495A patent/ES341495A1/es not_active Expired
- 1967-06-15 NL NL6708328A patent/NL6708328A/xx unknown
- 1967-06-26 SE SE914667A patent/SE363679B/xx unknown
- 1967-06-27 BE BE700570D patent/BE700570A/xx unknown
- 1967-06-27 FI FI178167A patent/FI44301B/fi active
- 1967-06-27 NO NO16876467A patent/NO124336B/no unknown
- 1967-06-28 DK DK334267A patent/DK120254B/da unknown
- 1967-06-28 AT AT603367A patent/AT287191B/de not_active IP Right Cessation
- 1967-06-28 CH CH917267A patent/CH526631A/de not_active IP Right Cessation
- 1967-06-28 DE DE19671617644 patent/DE1617644A1/de active Pending
1968
- 1968-08-27 DK DK412068A patent/DK120309B/da unknown

Also Published As

Publication number	Publication date
FI44301B (2)	1971-06-30
CH526631A (de)	1972-08-15
DE1617644A1 (de)	1971-04-08
DK120254B (da)	1971-05-03
NL6708328A (2)	1967-12-29
AT287191B (de)	1971-01-11
SE363679B (2)	1974-01-28
BE700570A (2)	1967-12-01
DK120309B (da)	1971-05-10
ES341495A1 (es)	1968-09-16

Publication	Publication Date	Title
US4960715A (en)	1990-10-02	Diagnostic test methods
US4332783A (en)	1982-06-01	Process for immunologic determination tests
US4508829A (en)	1985-04-02	Method and kit for pregnancy detection
EP0281327B1 (en)	1993-06-30	Immunoreactive reagent, method of preparation and its use to determine an immunoreactive species
US4711841A (en)	1987-12-08	Method for determining one or more antigens in a sample
US4259207A (en)	1981-03-31	Suspending medium for immunologic reactions
WO1980001515A1 (en)	1980-07-24	Improvements in or relating to processes and materials for detecting and determining proteinaceous specific binding agents and materials bindable thereto
KR0126236B1 (ko)	1997-12-24	완전 세포에 적용할 수 있는 면역측정분석 키트 및 방법
US4210622A (en)	1980-07-01	Kit for assay of immune complexes
US3562384A (en)	1971-02-09	Immunological indicator and test system
JPH01227962A (ja)	1989-09-12	低級アルコールスルフェート洗浄液，試験キットおよび免疫リガンドの測定方法
US4329151A (en)	1982-05-11	Stable diagnostic reagent and method for qualitative determinations of streptococci infections
JPH02156157A (ja)	1990-06-15	正荷電イオン性バインディング支持体を使用するクラミジア抗原または淋菌抗原の測定
JP3186831B2 (ja)	2001-07-11	血液型試薬としての凝集複合体
DE19842609C2 (de)	2000-09-21	Salmonellenantigengemisch und Kit zur Bestimmung von Antikörpern gegen Salmonellen
EP0362273A1 (en)	1990-04-11	Ice nucleation immunoassay
NO124336B (2)	1972-04-04
US4107287A (en)	1978-08-15	GC Antigen-specific immunochemical indicator reagent and method for preparing same
US5093235A (en)	1992-03-03	Immuno-dye reagent and assay for detection of endotoxin
CN111220802A (zh)	2020-06-02	基于纳米抗体的盐酸克伦特罗小分子半抗原高敏感性检测试纸及其制备方法
US4677080A (en)	1987-06-30	Rapid particle agglutination test for enterotoxigenic bacteria
US5017472A (en)	1991-05-21	Microflotation devices used for immunoassays and cell/molecular fractionation
JPS6058420B2 (ja)	1985-12-19	免疫反応用マイクロカプセル群及びそれを用いた判別方法
NO166258B (no)	1991-03-11	Fremgangsmaate for konsentrering og paavisning av biomolekyler og -celler og en anordning for dette.
CN108732346A (zh)	2018-11-02	一种藻蓝蛋白荧光探针及其用于黄曲霉毒素b1快速检测的方法